Tesamorelin 2mgs/vial (10vial)

Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH). It is designed to stimulate the production and release of growth hormone from the pituitary gland in the brain.

The description for Tesamorelin 2mg typically refers to a vial or ampoule containing 2 milligrams (mg) of the active ingredient tesamorelin. This medication is administered via subcutaneous injection.

Tesamorelin is primarily used for the treatment of excess abdominal fat in HIV-infected patients with lipodystrophy, a condition characterized by abnormal fat distribution in the body. It helps reduce visceral adipose tissue, which is the fat stored around the abdominal organs.

Patients prescribed Tesamorelin should adhere closely to their healthcare provider’s instructions regarding dosage, administration, and treatment duration. It’s important to note that Tesamorelin is not intended for weight loss or cosmetic purposes, but specifically for addressing the metabolic complications associated with HIV-related lipodystrophy. As with any medication, potential side effects and contraindications should be discussed with a healthcare professional prior to use.